Medical Biotechnology in Germany 2020

July 1, 2020 Medical Biotechnology in Germany 2020

The German biotech landscape holds immense potential for advanced therapy medicinal products.

Dr. Frank Mathias presented the annual industry report "Medical Biotechnology in Germany 2020 " by the Boston Consulting Group and vfa bio, as chairman of vfa bio, in Frankfurt, Germany, yesterday.

The consistent growth of the German biopharmaceutical sector is underlined in the report, reflected by an increase in market revenue, number of approvals, pipelines and employment generation in the sector. Furthermore, this year’s report focuses on advanced therapy medicinal products and accentuates the relevance of biopharmaceuticals in tackling the COVID-19 pandemic.

The full report can be downloaded here (Link) (German only, English abstract available).

 

 

 

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
communications@rentschler-biopharma.com